术前中性粒细胞增多对脑膜瘤无复发生存期的预后意义
研究分析222例新诊断脑膜瘤患者的术前血常规,51例(23%)存在中性粒细胞增多。单因素分析中中性粒细胞增多与肿瘤复发显著相关(HR 2.73,P<0.01),多因素校正肿瘤分级、大小和切除程度后仍为独立预后因素(HR 2.23,P=0.01);贫血(46例,21%)显示复发高风险趋势(HR 1.83,P=0.06)。
要点
- 术前中性粒细胞增多与脑膜瘤复发风险升高相关(HR 2.73,P<0.01)。
- 校正肿瘤分级、大小和切除程度后,中性粒细胞增多仍为独立预后因素(HR 2.23,P=0.01)。
- 贫血显示复发高风险趋势(HR 1.83,P=0.06),未达统计学显著。
核心结论
- 术前中性粒细胞增多与脑膜瘤患者更高的肿瘤复发率相关。
- 这些结果的验证及中性粒细胞炎症/免疫反应在脑膜瘤中的生物学作用需要进一步研究。
研究设计与样本
- 研究分析了222例新诊断脑膜瘤患者的术前全血细胞计数数据,获取了包括糖皮质激素治疗史、肿瘤特征和随访在内的临床资料。
- 采用Cox比例风险模型和log-rank检验评估无复发生存期。
主要发现
- 在任何类固醇治疗前使用术前全血细胞计数数据,51例(23%)患者存在中性粒细胞增多。
- 单因素分析中,中性粒细胞增多与脑膜瘤复发显著相关(HR 2.73,P<0.01)。
- 白细胞增多和淋巴细胞增多均与无复发生存期无关。
- 多因素分析中,校正肿瘤分级、肿瘤大小和切除程度后,中性粒细胞增多仍为无复发生存期的独立预后因素(HR 2.23,P=0.01)。
- 46例(21%)患者血红蛋白水平低提示贫血,贫血的存在显示复发高风险趋势(HR 1.83,P=0.06)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 这些结果的验证及中性粒细胞炎症/免疫反应在脑膜瘤中的生物学作用需要进一步研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Meningioma is the most common primary intracranial tumor and recurrence is one of the important challenges in patient management. Prognostic factors for tumor recurrences in these patients especially before surgical resection are not fully characterized. Several studies have indicated an association between changes in hematologic laboratory parameters with patient outcomes in solid malignancies. We aimed to assess the association between hematologic parameters and tumor recurrence in patients with meningioma. METHODS: Preoperative complete blood count (CBC) data were analyzed in patients with newly diagnosed meningioma (n = 222). Clinical data, including history of corticosteroid therapy, tumor characteristics, and follow-up, were obtained. Recurrence-free survival (RFS) was evaluated using Cox proportional hazards models and log-rank tests. RESULTS: Using preoperative CBC data from patients prior to any steroid therapy, 51 (23%) patients had neutrophilia. In univariate analysis, neutrophilia was significantly associated with meningioma recurrence (hazard ratio [HR] 2.73; P < 0.01). Neither leukocytosis nor lymphocytosis was associated with RFS. In multivariate analysis, after adjusting for tumor grade, tumor size, and extent of resection, neutrophilia remained an independent prognostic factor for RFS (HR 2.23, P = 0.01). Forty-six (21%) patients had low hemoglobin levels indicative of anemia, and the presence of anemia showed a trend toward high risk for recurrence (HR 1.83; P = 0.06). CONCLUSIONS: The presence of neutrophilia was associated with higher rate of tumor recurrence in patients with meningioma. Validation of these results and the biologic role of neutrophilic inflammatory/immune reaction in meningioma requires further investigation.
引用
- Karimi S, Vyas MV, Gonen L, et al. Prognostic significance of preoperative neutrophilia on recurrence-free survival in meningioma. Neuro Oncol. 2017. PMID: 28531342. doi:10.1093/neuonc/nox089
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。